Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04879654
PHASE2

Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Sponsor: Eye & ENT Hospital of Fudan University

View on ClinicalTrials.gov

Summary

Phase II, single-arm, prospective clinical study of Toripalimab(a PD-1 antibody) combined with radiotherapy and chemotherapy in the treatment of sinonasal malignant mucosal melanoma after endoscopic surgery.

Official title: Phase II, Single-arm, Prospective Clinical Study of Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of Sinonasal Malignant Mucosal Melanoma(SNMM) After Endoscopic Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2021-05-01

Completion Date

2026-05-01

Last Updated

2024-03-05

Healthy Volunteers

No

Interventions

PROCEDURE

endoscopic surgery

endoscopic surgery followed by multimodality treatment including radiotherapy,Toripalimab,and/or chemotherapy

Locations (1)

Eye& ENT Hospital, Fudan University

Shanghai, Shanghai Municipality, China